Medical Devices Series A Investors & VC Firms

1145 firms in this list, with a median first check of $500K. 237 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
BI Biovance Capital Partners SCR PVAAAPAA16 people	88🔒	Lisbon	PT	Seed–Series A	—	+ Add to CRM
DE Delft Enterprises B.V. RGJMEVJP16 people	88🔒	Delft	NL	Pre-Seed–Series A	—	+ Add to CRM
NI Nimbus Synergies Inc. JRAGBSLC13 people · Leads rounds	88🔒	Vancouver	CA	Pre-Seed–Series A	$250K – $2M	+ Add to CRM
IY Iyengar Capital Partners TBASCGEL15 people	88🔒	Clayton	US	Seed–Series B	—	+ Add to CRM
LA Laerdal Million Lives Fund JTBSDSJJ9 people	88🔒	San Francisco	US	Series A–Series B	$1M – $5M	+ Add to CRM
DE Detong Capital JTRSSJTL11 people	88🔒	Shanghai	CN	Seed–Late Stage	$20M	+ Add to CRM
SU Suncoast Ventures GLHWJHMR14 people	88🔒	Walnut Creek	US	Pre-Seed–Series A	—	+ Add to CRM
AR Arc Angels	88🔒	Auckland	NZ	Pre-Seed–Late Stage	—	+ Add to CRM
BO Borealis Ventures DCJSPFBS12 people	88🔒	Hanover	US	Pre-Seed–Series A	$1M – $2.5M	+ Add to CRM
BU Business Growth Fund BJABAGAS9 people · Follows rounds	88🔒	London	GB	Seed–Growth	$3.8M – $38M	+ Add to CRM
IM Impact Ventures BMEEGIÁH6 people	88🔒	Budapest	HU	Seed–Series A	$378K – $1.6M	+ Add to CRM
NU Nueterra Capital DTJTBTEE6 people	88🔒	Leawood	US	Seed–Late Stage	—	+ Add to CRM
OR ORI Capital SSDTGSYE15 people	88🔒	Hong Kong	HK	Pre-Seed–Late Stage	—	+ Add to CRM
TE Texas Ventures ESACAVHM6 people	88🔒	Houston	US	Seed–Late Stage	—	+ Add to CRM
TH Think.Health FKMRNB3 people	88🔒	Berlin	DE	Seed–Growth	$550K – $11M	+ Add to CRM
AS Asia2G Capital AJAKIHJJ5 people	88🔒	Silicon Valley	US	Pre-Seed–Series A	—	+ Add to CRM
GE Gefen Capital DWDWLGSI8 people	88🔒	Herzliya Pituach	IL	Seed–Series B	—	+ Add to CRM
MR MRL Ventures Fund PDJRKKOD5 people · Leads rounds	88🔒	Cambridge	US	Pre-Seed–Series B	$25M	+ Add to CRM
MV MVM Life Science Partners EBEFHHJT11 people	88🔒	London	GB	Seed–Late Stage	$20M – $100M	+ Add to CRM
IS ISA Ventures EE1 person	88🔒	Cedar Rapids	US	Pre-Seed–Late Stage	$25K – $1M	+ Add to CRM
ST StartAngels Network LW1 person · Leads rounds	88🔒	Zürich	CH	Pre-Seed–Series A	—	+ Add to CRM
IN Innvotec Ltd. MTNDSPST4 people	88🔒	London	GB	Series A–Series B	$317.5K – $635K	+ Add to CRM
JS JStar Capital Investments EPJLBBDD13 people	88🔒	Austin	US	Seed–Late Stage	—	+ Add to CRM
AG AgeTech Capital AMBSLLST15 people	88🔒	Toronto	CA	Pre-Seed–Growth	—	+ Add to CRM

Biovance Capital Partners SCR

LisbonSeed–Series A

PVAAAPAA16 people

Delft Enterprises B.V.

DelftPre-Seed–Series A

RGJMEVJP16 people

Nimbus Synergies Inc.

VancouverPre-Seed–Series A$250K – $2M

JRAGBSLC13 people

Iyengar Capital Partners

ClaytonSeed–Series B

TBASCGEL15 people

Laerdal Million Lives Fund

San FranciscoSeries A–Series B$1M – $5M

JTBSDSJJ9 people

Detong Capital

ShanghaiSeed–Late Stage$20M

JTRSSJTL11 people

Suncoast Ventures

Walnut CreekPre-Seed–Series A

GLHWJHMR14 people

Arc Angels

AucklandPre-Seed–Late Stage

Borealis Ventures

HanoverPre-Seed–Series A$1M – $2.5M

DCJSPFBS12 people

Business Growth Fund

LondonSeed–Growth$3.8M – $38M

BJABAGAS9 people

Impact Ventures

BudapestSeed–Series A$378K – $1.6M

BMEEGIÁH6 people

Nueterra Capital

LeawoodSeed–Late Stage

DTJTBTEE6 people

ORI Capital

Hong KongPre-Seed–Late Stage

SSDTGSYE15 people

Texas Ventures

HoustonSeed–Late Stage

ESACAVHM6 people

Think.Health

BerlinSeed–Growth$550K – $11M

FKMRNB3 people

Asia2G Capital

Silicon ValleyPre-Seed–Series A

AJAKIHJJ5 people

Gefen Capital

Herzliya PituachSeed–Series B

DWDWLGSI8 people

MRL Ventures Fund

CambridgePre-Seed–Series B$25M

PDJRKKOD5 people

MVM Life Science Partners

LondonSeed–Late Stage$20M – $100M

EBEFHHJT11 people

ISA Ventures

Cedar RapidsPre-Seed–Late Stage$25K – $1M

EE1 person

StartAngels Network

ZürichPre-Seed–Series A

LW1 person

Innvotec Ltd.

LondonSeries A–Series B$317.5K – $635K

MTNDSPST4 people

JStar Capital Investments

AustinSeed–Late Stage

EPJLBBDD13 people

AgeTech Capital

TorontoPre-Seed–Growth

AMBSLLST15 people

Data sourced from public filings and firms' own websites — see our methodology.